Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Victoria Ferrari

4PUBLICATIONS

10CO-AUTHORS

Predictive and prognostic markersCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (4)

Sort by Publication Date:

|Jul 12, 2025

PD-L1 Expression in NSCLC: Clouds in a Bright Sky.

Victoria Ferrari, Jocelyn Gal, Baharia Mograbi

|Sep 28, 2024

Companion Tests and Personalized Cancer Therapy: Reaching a Glass Ceiling.

Victoria Ferrari, Baharia Mograbi, Jocelyn Gal

|Jun 27, 2024

Plasmatic Inactive IL-18 Predicts a Worse Overall Survival for Advanced Non-Small-Cell Lung Cancer with Early Metabolic Progression after Immunotherapy Initiation.

Serena Janho Dit Hreich, Olivier Humbert, Tanguy Pacé-Loscos

|May 11, 2024

Revolutionizing Localized Lung Cancer Treatment: Neoadjuvant Chemotherapy plus Immunotherapy for All?

Victoria Ferrari, Carole Helissey

Pageof 1

Frequent Collaborators

2 joint publications

Baharia Mograbi

2 joint publications

Jocelyn Gal

1 joint publications

Carole Helissey

1 joint publications

Serena Janho Dit Hreich

1 joint publications

Tanguy Pacé-Loscos

1 joint publications

Renaud Schiappa

1 joint publications

Marius Ilié

1 joint publications

Jonathan Benzaquen

1 joint publications

Paul Hofman

1 joint publications

Valérie Vouret-Craviari

Frequent Collaborators

2 joint publications

Baharia Mograbi

2 joint publications

Jocelyn Gal

1 joint publications

Carole Helissey

1 joint publications

Serena Janho Dit Hreich

Top Related Videos

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on : Aug 14, 2019

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on : Jul 25, 2020

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on : Feb 07, 2021

See more related videos

Top Related Videos

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on : Aug 14, 2019

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on : Jul 25, 2020

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on : Feb 07, 2021

See more related videos